SOL SpA

  • Market Cap: N/A
  • Industry: Specialty Chemicals
  • ISIN: IT0001206769
EUR
48.75
-0.05 (-0.1%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate 3.99% of over the last 5 years

 
2

With ROE of 0.54%, it has a Very Expensive valuation with a 4.26 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

EUR 4,390 Million ()

stock-summary
P/E

786.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.81%

stock-summary
Debt Equity

0.41

stock-summary
Return on Equity

0.54%

stock-summary
Price to Book

4.14

Revenue and Profits:
Net Sales:
150 Million
(Quarterly Results - Dec 2012)
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.25%
0%
-6.25%
6 Months
2.09%
0%
2.09%
1 Year
33.02%
0%
33.02%
2 Years
84.66%
0%
84.66%
3 Years
166.68%
0%
166.68%
4 Years
138.39%
0%
138.39%
5 Years
262.45%
0%
262.45%

SOL SpA for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
7.66%
EBIT Growth (5y)
3.99%
EBIT to Interest (avg)
21.02
Debt to EBITDA (avg)
1.41
Net Debt to Equity (avg)
0.35
Sales to Capital Employed (avg)
0.44
Tax Ratio
41.63%
Dividend Payout Ratio
23.95%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.49%
ROE (avg)
1.94%
Valuation key factors
Factor
Value
P/E Ratio
786
Industry P/E
Price to Book Value
4.25
EV to EBIT
99.53
EV to EBITDA
41.81
EV to Capital Employed
3.31
EV to Sales
8.48
PEG Ratio
NA
Dividend Yield
0.78%
ROCE (Latest)
3.32%
ROE (Latest)
0.54%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by SOL SpA"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 8.29% vs 7.82% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 1.51% vs 10.97% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,610.40",
          "val2": "1,487.10",
          "chgp": "8.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "361.90",
          "val2": "331.90",
          "chgp": "9.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "24.70",
          "val2": "17.70",
          "chgp": "39.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.40",
          "val2": "18.60",
          "chgp": "-112.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "155.00",
          "val2": "152.70",
          "chgp": "1.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "127.60%",
          "val2": "125.80%",
          "chgp": "0.18%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,610.40
1,487.10
8.29%
Operating Profit (PBDIT) excl Other Income
361.90
331.90
9.04%
Interest
24.70
17.70
39.55%
Exceptional Items
-2.40
18.60
-112.90%
Consolidate Net Profit
155.00
152.70
1.51%
Operating Profit Margin (Excl OI)
127.60%
125.80%
0.18%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 8.29% vs 7.82% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 1.51% vs 10.97% in Dec 2023

stock-summaryCompany CV
About SOL SpA stock-summary
stock-summary
SOL SpA
Specialty Chemicals
SOL SpA is an Italy-based company primarily engaged in the research, production and distribution of industrial, pure and medicinal gases. It is also involved in the home care medical business. The Company’s product portfolio includes oxygen, nitrogen, hydrogen, argon, sulfur hexafluoride, carbon dioxide, ozone, helium and mixtures of medicinal gases, among others. Through its subsidiaries, the Company is involved in the provision of home care services, such as oxygen therapy, mechanical ventilation, diagnosis and care of obstructive sleep apnea syndrome, artificial nutrition, telemedicine, health assistance, and the prevention and treatment of skin ulcers. Additionally, it is engaged in the supply and management of medical and technological devices for home care. As of December 31, 2011, the Company had a number of subsidiaries, including Airsol BV, Biotechsol Srl, CTS Srl, Energetika ZJ doo, GTH Gaze Industriale SA, Cryolab Srl, GTS Shpk and Hydroenergy Shpk, among others.
Company Coordinates stock-summary
Company Details
Via Borgazzi, 27 , MONZA None : 20900
stock-summary
Tel: 39 039 23961
stock-summary
Registrar Details